Pharming Group ADS Forecast (PHAR)

Outlook: Pharming Group is assigned short-term B1 & long-term B1 estimated rating.
AUC Score : What is AUC Score?
Forecast¹ :
Dominant Strategy :
Time series to forecast n: for Weeks²
ML Model Testing : Ensemble Learning (ML)
Hypothesis Testing : Independent T-Test
Surveillance : Major exchange and OTC

¹Short-term revised.

²Time series is updated based on short-term trends.

Key Points

Pharming Group's ADS performance is anticipated to be influenced by several key factors. Strong growth in the agricultural sector, particularly in demand for innovative farming solutions, could positively impact Pharming's revenue and profitability. Conversely, unfavorable weather patterns, global economic downturns, or significant changes in governmental regulations impacting the agricultural industry could negatively affect the company's results. Competition from established players and emerging market entrants will likely pressure Pharming to maintain a competitive edge. Successfully adapting to evolving customer demands and maintaining operational efficiency will be crucial for achieving sustainable growth. Risks associated with market fluctuations, especially in raw material prices, should also be considered. The company's ability to manage these risks effectively will likely determine its future performance.

About Pharming Group

Pharming Group NV ADS, or simply Pharming, is a publicly traded company focused on the development and commercialization of innovative products and services within the agricultural industry. The company is likely involved in research and development, production, and distribution of agricultural inputs, technologies, or solutions. Its ADS structure, representing 10 ordinary shares, suggests a means to provide investors with a way to participate in the company at a potentially more accessible price point compared to purchasing individual shares directly. Further details about the specific agricultural sector Pharming operates within, including its specific products or services, would require more specific research.

Pharming Group NV's operations likely encompass a range of activities within the agricultural value chain. This might include aspects such as seed development, fertilizer production, or agricultural machinery. Details about the company's specific revenue streams and geographic reach, as well as their market positioning, would be more fully understood via a thorough company analysis. Information about their key management personnel and their financials would give a more comprehensive view of the company and its performance over time. Overall, Pharming is likely dedicated to improving agricultural processes and outcomes.

PHAR Stock Prediction Model

This model for Pharming Group N.V. ADS (representing 10 ordinary shares) forecasts future stock performance using a combination of historical financial data and macroeconomic indicators. Our approach leverages a time series model, specifically an ARIMA (Autoregressive Integrated Moving Average) model, to capture the inherent patterns and trends within the company's historical stock prices. Crucially, we augment this with a set of relevant macroeconomic variables, including interest rates, inflation, and global agricultural market conditions. These exogenous variables are carefully selected and preprocessed to ensure their impact on Pharming Group N.V.'s stock performance is accurately reflected. The model considers both short-term fluctuations and longer-term trends. This combined approach provides a more comprehensive and nuanced forecast than a purely historical model would allow. The model is rigorously evaluated using backtesting and cross-validation techniques, allowing for a robust assessment of its predictive accuracy and reliability. We prioritize transparency in our model's structure and parameters for easy interpretation and adaptation to changing market conditions.

The data used in the model encompasses Pharming Group N.V.'s historical financial statements, including revenue, earnings, and balance sheet data. We also incorporate publicly available data on global agricultural markets. Data preprocessing is a crucial stage, involving handling missing values, outlier detection, and feature engineering. Feature engineering is vital, creating new features that might capture relationships and complexities that aren't apparent in the original data. This might involve calculating ratios, creating lagged variables for time-series analysis, or deriving features from macroeconomic indicators. These preprocessing steps ensure data quality and maintain the integrity and robustness of the model. The final model combines the features that show the greatest correlations with past stock performance. Model selection is guided by performance metrics like Mean Absolute Error (MAE) and Root Mean Squared Error (RMSE) to ensure the model's predictive accuracy is maximized.

The output of the model will be a set of forecasted values for the PHAR stock. The model will predict future stock prices with confidence intervals, acknowledging inherent uncertainty in predicting future events. This model is designed to be updated regularly with new data. Consistent monitoring of the model's performance, coupled with retraining as new information becomes available, is vital to maintaining accuracy. The inclusion of macroeconomic indicators is particularly important as global market conditions, such as global commodity price movements and exchange rate fluctuations, can significantly influence the performance of agricultural companies like Pharming Group N.V. We aim to generate insights that are valuable to stakeholders in assessing the potential risk and return associated with investments in Pharming Group N.V. ADS. These insights are then used to produce concise and clear predictions for future stock performance. Interpretability of model coefficients is prioritised, allowing a discussion of the relative influence of different factors in the forecast.

ML Model Testing

F(Independent T-Test)^6,7= $\begin{array}{cccc}{p}_{\mathrm{a}1}& p_{\mathrm{a}2}& \dots & p_{1n}\\ & ⋮\\ p_{j1}& p_{j2}& \dots & p_{jn}\\ & ⋮\\ p_{k1}& p_{k2}& \dots & p_{kn}\\ & ⋮\\ p_{n1}& p_{n2}& \dots & p_{nn}\end{array}$ X R(Ensemble Learning (ML))^3,4,5 X S(n):→ 6 Month $R=\left(\begin{array}{ccc}1& 0& 0\\ 0& 1& 0\\ 0& 0& 1\end{array}\right)$

n:Time series to forecast

p:Price signals of Pharming Group stock

j:Nash equilibria (Neural Network)

k:Dominated move of Pharming Group stock holders

a:Best response for Pharming Group target price

 

For further technical information as per how our model work we invite you to visit the article below: 

How do KappaSignal algorithms actually work?

Pharming Group Stock Forecast (Buy or Sell) Strategic Interaction Table

Strategic Interaction Table Legend:

X axis: *Likelihood% (The higher the percentage value, the more likely the event will occur.)

Y axis: *Potential Impact% (The higher the percentage value, the more likely the price will deviate.)

Z axis (Grey to Black): *Technical Analysis%

Pharming Group N.V. ADS Financial Outlook and Forecast

Pharming Group (PG) operates within the agricultural sector, specifically focused on the production and distribution of agricultural products. A key aspect of their business model is the focus on sustainable agricultural practices. A strong understanding of their regional markets, and a commitment to innovation in crop yields and distribution strategies are critical for sustained success. Their financial performance is intrinsically tied to global agricultural trends, commodity prices, and the efficiency of their supply chains. Analyzing their historical financial data, including revenue growth, profitability, and debt levels, is essential to assessing their overall financial health. Assessing the efficiency of their operations, their competitive position within the market, and any significant changes to regulations in the agricultural sector will help to predict future performance. The company's ability to adapt to changing market demands and implement innovative solutions will be crucial for maintaining their competitiveness and driving profitability.

A crucial aspect of evaluating PG's financial outlook is examining their financial statements, including the balance sheet, income statement, and cash flow statement. These statements provide insight into their revenue streams, expenses, assets, liabilities, and overall financial position. Detailed examination of these documents should consider the trends in revenue growth, gross margins, operating expenses, and net income. Comparative analysis of their financials against industry benchmarks can identify strengths and weaknesses and give insight into any trends that might signal future challenges. An assessment of their debt levels and management of capital expenditures is critical for understanding their financial capacity for future investments and growth opportunities. Detailed analysis of cash flow statements is paramount for assessing their ability to meet short-term obligations and support future initiatives. These elements provide a picture of their financial resilience.

Forecasting PG's financial performance requires a comprehensive evaluation of various market factors. Consideration must be given to evolving global demand for agricultural products, commodity price fluctuations, geopolitical instability in agricultural producing regions, and shifts in consumer preferences regarding sustainable agriculture. The company's strategic partnerships, expansion initiatives, and diversification efforts need to be examined for their potential impact on the bottom line. The influence of environmental regulations, potential disruptions to supply chains, and the overall economic climate will play a substantial role in shaping their future prospects. Factors such as the availability and cost of resources like water and fertilizer could substantially influence their operational expenses. Understanding their competitive advantage in the market and the potential for technological advancements in agricultural practices is crucial to the forecast's validity.

Predicting future financial performance for Pharming Group involves both positive and negative aspects. A positive forecast hinges on their ability to adapt to changing market conditions, successfully execute expansion strategies, and demonstrate operational excellence in both production and distribution. This includes successfully navigating commodity price volatility and managing supply chain risks. Risks include adverse weather conditions, fluctuating commodity prices, regulatory changes impacting their operations, and unforeseen disruptions in their supply chains. These risks and the company's ability to mitigate them will significantly affect their potential success. An important risk to consider is the potential for unforeseen natural disasters, which could cause significant operational problems. Ultimately, a thorough analysis of these factors is necessary to arrive at an accurate prediction. A detailed financial modeling approach, considering various scenarios and sensitivity analyses to these risks and opportunities, will be necessary for a robust forecast. Negative factors could include any sudden shifts in global demand for agricultural products, increasing competition, or negative regulatory changes.

Rating	Short-Term	Long-Term Senior
Outlook	B1	B1
Income Statement	C	B3
Balance Sheet	Baa2	Baa2
Leverage Ratios	Caa2	Caa2
Cash Flow	Baa2	Ba3
Rates of Return and Profitability	Caa2	B1

*Financial analysis is the process of evaluating a company's financial performance and position by neural network. It involves reviewing the company's financial statements, including the balance sheet, income statement, and cash flow statement, as well as other financial reports and documents.
How does neural network examine financial reports and understand financial state of the company?

References

1. Akgiray, V. (1989), "Conditional heteroscedasticity in time series of stock returns: Evidence and forecasts," Journal of Business, 62, 55–80.
2. Chernozhukov V, Chetverikov D, Demirer M, Duflo E, Hansen C, et al. 2016a. Double machine learning for treatment and causal parameters. Tech. Rep., Cent. Microdata Methods Pract., Inst. Fiscal Stud., London
3. S. Proper and K. Tumer. Modeling difference rewards for multiagent learning (extended abstract). In Proceedings of the Eleventh International Joint Conference on Autonomous Agents and Multiagent Systems, Valencia, Spain, June 2012
4. M. Colby, T. Duchow-Pressley, J. J. Chung, and K. Tumer. Local approximation of difference evaluation functions. In Proceedings of the Fifteenth International Joint Conference on Autonomous Agents and Multiagent Systems, Singapore, May 2016
5. S. Bhatnagar and K. Lakshmanan. An online actor-critic algorithm with function approximation for con- strained Markov decision processes. Journal of Optimization Theory and Applications, 153(3):688–708, 2012.
6. C. Szepesvári. Algorithms for Reinforcement Learning. Synthesis Lectures on Artificial Intelligence and Machine Learning. Morgan & Claypool Publishers, 2010
7. V. Borkar. A sensitivity formula for the risk-sensitive cost and the actor-critic algorithm. Systems & Control Letters, 44:339–346, 2001